Cohen Capital Management Inc. Sells 137 Shares of Solventum Co. (NYSE:SOLV)

Cohen Capital Management Inc. lessened its holdings in Solventum Co. (NYSE:SOLVFree Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,195 shares of the company’s stock after selling 137 shares during the quarter. Cohen Capital Management Inc.’s holdings in Solventum were worth $740,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in SOLV. Modus Advisors LLC purchased a new stake in shares of Solventum during the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC bought a new stake in Solventum during the 4th quarter valued at $26,000. True Wealth Design LLC raised its holdings in Solventum by 23,550.0% during the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after buying an additional 471 shares during the last quarter. Crews Bank & Trust purchased a new stake in Solventum during the 4th quarter valued at $32,000. Finally, Prospera Private Wealth LLC bought a new stake in Solventum in the 3rd quarter worth $35,000.

Analysts Set New Price Targets

Several brokerages have recently commented on SOLV. Mizuho initiated coverage on shares of Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Piper Sandler upped their price target on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Finally, Morgan Stanley increased their price objective on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $68.29.

Read Our Latest Report on Solventum

Solventum Price Performance

Shares of SOLV opened at $73.08 on Friday. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The company has a 50-day simple moving average of $71.14 and a two-hundred day simple moving average of $69.15. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

About Solventum

(Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

See Also

Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Solventum Co. (NYSE:SOLVFree Report).

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.